CDRHNew
Date: July 15, 2014
The following new items were added to the CDRH web pages on July 14, 2014. Previous CDRH New Items can be found on the CDRHNew Page.
- Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications [510(k)] with Different Technological Characteristics - Draft Guidance for Industry and Food and Drug Administration Staff
- Presentations posted for July 10-11, 2014 Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee Meeting
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
